Coala Life, a healthcare technology company based out of Sweden, has announced that physicians will now be able to use the company’s Coala Heart Monitor to conduct virtual heart and lung examinations.
The smartphone-powered device, available by prescription to users in the United States and some parts of Europe, helps physicians read and analyze electrocardiogram data and assess respiratory recordings without the patient ever leaving the comfort of home.
“The Coala device was developed and validated in Sweden based on over 10 years of research,” Philip Siberg, Coala Life founder and president, said in a prepared statement. “It truly enables telemedicine with the ability to monitor respiratory sounds and cardiac related conditions in the safety of patients' homes and help eliminate the need for patient office visits.”
In March 2020, the FDA published a guidance document focused on the importance of patient monitoring during the COVID-19 pandemic.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.